{
    "body": "What is the purpose of HaploReg v4?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26657631", 
        "http://www.ncbi.nlm.nih.gov/pubmed/27539526"
    ], 
    "ideal_answer": [
        "HaploReg v4 enables the systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease."
    ], 
    "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056726"
    ], 
    "type": "summary", 
    "id": "587f60f892a5b8ad44000004", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 137, 
            "text": "HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26657631", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 725, 
            "offsetInEndSection": 1351, 
            "text": "Since first launching the website in 2011, we have greatly expanded HaploReg, increasing the number of chromatin state maps to 127 reference epigenomes from ENCODE 2012 and Roadmap Epigenomics, incorporating regulator binding data, expanding regulatory motif disruption annotations, and integrating expression quantitative trait locus (eQTL) variants and their tissue-specific target genes from GTEx, Geuvadis, and other recent studies. We present these updates as HaploReg v4, and illustrate a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putative brain regulatory mechanisms.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26657631", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1158, 
            "offsetInEndSection": 1347, 
            "text": "We present these updates as HaploReg v4, and illustrate a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putative brain regulatory mechanisms.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26657631", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1162, 
            "offsetInEndSection": 1351, 
            "text": "We present these updates as HaploReg v4, and illustrate a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putative brain regulatory mechanisms.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26657631", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 828, 
            "offsetInEndSection": 921, 
            "text": "HaploReg V4.1 and Regulome DB were used to understand functional annotation on important SNV.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/27539526", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 138, 
            "text": "HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26657631", 
            "endSection": "title"
        }
    ]
}